NORTHWEST BIOTHERAPEUTICS INC Common Stock

YTD

ALL

Why Robinhood?

You can watch NWBO and buy or sell other stocks, ETFs, and their options commission-free!

About NWBO

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.

CEO

Linda F. Powers

CEOLinda F. Powers

Employees

Employees25

Headquarters

Bethesda, Maryland

HeadquartersBethesda, Maryland

Founded

1996

Founded1996

Employees

Employees25

NWBO Key Statistics

Market cap

380.88M

Market cap380.88M

Price-Earnings ratio

-3.92

Price-Earnings ratio-3.92

Dividend yield

—

Dividend yield—

Average volume

5.05M

Average volume5.05M

High today

$0.26

High today$0.26

Low today

$0.2483

Low today$0.2483

Open price

$0.2559

Open price$0.2559

Volume

1.51M

Volume1.51M

52 Week high

$0.4788

52 Week high$0.4788

52 Week low

$0.1685

52 Week low$0.1685

NORTHWEST BIOTHERAPEUTICS INC Common Stock

Why Robinhood?

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. Show more

NWBO Key Statistics

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.